In clinical settings, simultaneous monitoring of serum and serum EV hsa_circ_0041150 along with NSE (Neuron-Specific Enolase) can significantly enhance the sensitivity and specificity of diagnosing chemotherapy resistance in SCLC. Here, ENO2 is linked to small cell lung carcinoma.